STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Company

ROCKET PHARMACEUTICALS, INC.

Filed

December 16, 2024

Period of Report

December 12, 2024

Accession Number

0001062993-24-020690